Clinical and dosimetric variables | Patient 1 | Patient 2 | Patient 3 | Patient 4 |
Tumor characteristic | ||||
Size | 14.7 | 8.3 | 10.6 | 12 |
No. of lesions | 1 | 4 | 1 | 1 |
PVT | Branch | No | Branch | Branch |
Child–Pugh | B7 | A5 | A6 | A5 |
Standard plan | ||||
IAplan (GBq) | 2.5 | 2.5 | 5 | 5 |
Tplan D (Gy) | 187 | 177, 216, 297, 426 | 257 | 201 |
ILplan D (Gy) | 148 | 110 | 131 | 106 |
IHLplan D (Gy) | 77 | 66 | 66 | 44 |
Optimized plan | ||||
IAplan (GBq) | 3.5 | 3.5 | 7.5 | 6.5 |
Tplan D (Gy) | 229 | 250, 305, 419, 601 | 349 | 265 |
ILplan D (Gy) | 175 | 154 | 196 | 138 |
IHLplan D (Gy) | 94 | 93 | 92 | 58 |
Follow-up | ||||
Duration (mo) | 10 | 12 | 15 | 11 |
Response | Stable disease | PR | PR | PR |
Liver toxicity | No | No | No | No |
ILplan D = injected liver planning dose; IHLplan D = injected healthy liver planning dose.